Tumor infiltrating lymphocytes with expression of these checkpoint inhibitors had higher expression of activation markers, but similar or lower levels of granzyme B expression compared to tumor infiltrating lymphocytes not expressing these checkpoints (44). Here, GZMB is linked to neoplasm.